Inir 10mg, 18mg, 25mg, 40mg, 60mg Capsule
PDF Leaflet Revision Date: 25 November 2016
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of ADHD in children 6 years and older, adolescents, and adults.
Dosage (summary)
Children <70 kg: 0.5 mg/kg, maintenance 1.2 mg/kg/day; Adults: Initiate at 40 mg, maintenance 80 mg.
Onset of Action / Duration
Onset: 1-2 hours, Duration: Not specified.
Special Populations
- Hepatic impairment
- End-stage renal disease
Pregnancy & Breastfeeding
No adequate studies in pregnancy; unknown if excreted in human milk.
Key Drug Interactions
- MAOIs
- Beta-adrenergic agonists
- CYP2D6 inhibitors
Contraindications
- Hypersensitivity to atomoxetine
- Uncontrolled hypertension
- Narrow angle glaucoma
Common side effects
- Decreased appetite
- Suicidal ideation
- Mood swings
- Dizziness
- Palpitations
Counselling Points
- Monitor for mood changes
- Use caution when driving
- Do not open capsules
- Report jaundice or liver symptoms
Serious warnings
- Risk of suicidal behavior
- Liver injury
- Mood swings
- Cardiovascular effects
On This Page
Loading package insert…
Medinsert AI
Hello! I am Medinsert Ai. What would you like to know about this professional information leaftleft?